Concepedia

Pam Lacock

PL

Statistics

Publications

3

Citations

187

H-Index

3

Active since

1999

Affiliations

Center for Clinical Research (United States)(Current)

Ohio Heart & Vascular Center

Lindner Center of HOPE

Community Health Alliance

Christ Hospital

Pam Lacock is an author at Center for Clinical Research (United States) specializing in pharmacology, platelet function, and platelet inhibition.

Publications per year

1999–2000

3

Publications

3

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

Dean J. Kereiakes, Thomas M. Broderick, Eli M. Roth et al. · The American Journal of Cardiology · 1999 · 134 citations

, , +17

Efficacy of Abciximab Induced Platelet Blockade Using a Rapid Point of Care Assay

Michele Mueller, W L HOWARD, Pam Lacock et al. · Journal of Thrombosis and Thrombolysis · 1999 · 41 citations

, , +15

High Platelet Count in Platelet-Rich Plasma Reduces Measured Platelet Inhibition by Abciximab but not Tirofiban nor Eptifibatide Glycoprotein IIb/IIIa Receptor Antagonists

Dean J. Kereiakes, Thomas M. Broderick, Eli M. Roth et al. · Journal of Thrombosis and Thrombolysis · 2000 · 12 citations

, , +15

1–3 of 3